News
The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 billion in 2025 and an impressive US$1,034.78 billion ...
Injectable Drug Delivery Market worth US$1,034.78 billion by 2030 with 8.4% CAGR | MarketsandMarkets
The global Injectable Drug Delivery Market, valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 ...
Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.
Reforming Medicare Drug Price Negotiations under the ... whereas biologics are generally only available via parenteral routes of administration (i.e., via injection). The Executive Order addresses ...
and clinical manufacturing services for inhaled and nasal drug products—is a response to the globally rising demand from clients for inhaled biologics (1). Such routes of administration are effective ...
Research and development expenses for the first quarter of 2025 increased to $9.1 million from $7.7 million for the prior ...
Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...
Administer medications via the oral route when possible ... tube feeding for at least one to two hours before and after medication administration if drug absorption may be affected.
The global adrenogenital syndrome treatment market is poised for sustained growth, expected to expand from USD 14.2 billion in 2025 to USD 24.5 billion by 2035, registering a compound annual growth ...
In April 2025, Incyte Corporation announced a study will be conducted to compare the efficacy of axatilimab versus placebo in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results